The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global End Stage Renal Disease (ESRD) Treatment Market Research Report 2025

Global End Stage Renal Disease (ESRD) Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1686527

No of Pages : 90

Ask Your Query
Synopsis
End-stage renal failure, also known as end-stage renal disease (ESRD), is can be caused by an underlying health problem, often diabetes or high blood pressure. ESRD is the final, permanent stage of chronic kidney disease, where kidney function has declined to the point that the kidneys can no longer function on their own. When the kidneys can no longer filter the blood of waste and extra fluid, patients need dialysis or a kidney transplant to survive.
The report studies End Stage Renal Disease Treatment market including three main methods of treatment: Hemodialysis, Kidney transplant and Peritoneal dialysis.
The global End Stage Renal Disease (ESRD) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for End Stage Renal Disease (ESRD) Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding End Stage Renal Disease (ESRD) Treatment.
Report Scope
The End Stage Renal Disease (ESRD) Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global End Stage Renal Disease (ESRD) Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the End Stage Renal Disease (ESRD) Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Fresenius
DaVita
Baxter
Nipro
B. Braun
Asahi Kasei
Nikkiso
WEGO
Newsol
Mayo Clinic
Guangdong Biolight
Medtronic
Sanxin Medtec
Jafron Biomedical
SWS Hemodialysis Care
Tianyi Medical
Segment by Type
Hemodialysis
Peritoneal Dialysis
Kidney Transplantation
Segment by Application
Hospitals
Kidney Dialysis Centers
At Homes
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of End Stage Renal Disease (ESRD) Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global End Stage Renal Disease (ESRD) Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Hemodialysis
1.2.3 Peritoneal Dialysis
1.2.4 Kidney Transplantation
1.3 Market by Application
1.3.1 Global End Stage Renal Disease (ESRD) Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Kidney Dialysis Centers
1.3.4 At Homes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global End Stage Renal Disease (ESRD) Treatment Market Perspective (2019-2030)
2.2 End Stage Renal Disease (ESRD) Treatment Growth Trends by Region
2.2.1 Global End Stage Renal Disease (ESRD) Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 End Stage Renal Disease (ESRD) Treatment Historic Market Size by Region (2019-2024)
2.2.3 End Stage Renal Disease (ESRD) Treatment Forecasted Market Size by Region (2025-2030)
2.3 End Stage Renal Disease (ESRD) Treatment Market Dynamics
2.3.1 End Stage Renal Disease (ESRD) Treatment Industry Trends
2.3.2 End Stage Renal Disease (ESRD) Treatment Market Drivers
2.3.3 End Stage Renal Disease (ESRD) Treatment Market Challenges
2.3.4 End Stage Renal Disease (ESRD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top End Stage Renal Disease (ESRD) Treatment Players by Revenue
3.1.1 Global Top End Stage Renal Disease (ESRD) Treatment Players by Revenue (2019-2024)
3.1.2 Global End Stage Renal Disease (ESRD) Treatment Revenue Market Share by Players (2019-2024)
3.2 Global End Stage Renal Disease (ESRD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by End Stage Renal Disease (ESRD) Treatment Revenue
3.4 Global End Stage Renal Disease (ESRD) Treatment Market Concentration Ratio
3.4.1 Global End Stage Renal Disease (ESRD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by End Stage Renal Disease (ESRD) Treatment Revenue in 2023
3.5 End Stage Renal Disease (ESRD) Treatment Key Players Head office and Area Served
3.6 Key Players End Stage Renal Disease (ESRD) Treatment Product Solution and Service
3.7 Date of Enter into End Stage Renal Disease (ESRD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 End Stage Renal Disease (ESRD) Treatment Breakdown Data by Type
4.1 Global End Stage Renal Disease (ESRD) Treatment Historic Market Size by Type (2019-2024)
4.2 Global End Stage Renal Disease (ESRD) Treatment Forecasted Market Size by Type (2025-2030)
5 End Stage Renal Disease (ESRD) Treatment Breakdown Data by Application
5.1 Global End Stage Renal Disease (ESRD) Treatment Historic Market Size by Application (2019-2024)
5.2 Global End Stage Renal Disease (ESRD) Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America End Stage Renal Disease (ESRD) Treatment Market Size (2019-2030)
6.2 North America End Stage Renal Disease (ESRD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America End Stage Renal Disease (ESRD) Treatment Market Size by Country (2019-2024)
6.4 North America End Stage Renal Disease (ESRD) Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe End Stage Renal Disease (ESRD) Treatment Market Size (2019-2030)
7.2 Europe End Stage Renal Disease (ESRD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe End Stage Renal Disease (ESRD) Treatment Market Size by Country (2019-2024)
7.4 Europe End Stage Renal Disease (ESRD) Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Size (2019-2030)
8.2 Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America End Stage Renal Disease (ESRD) Treatment Market Size (2019-2030)
9.2 Latin America End Stage Renal Disease (ESRD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America End Stage Renal Disease (ESRD) Treatment Market Size by Country (2019-2024)
9.4 Latin America End Stage Renal Disease (ESRD) Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Size (2019-2030)
10.2 Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Fresenius
11.1.1 Fresenius Company Detail
11.1.2 Fresenius Business Overview
11.1.3 Fresenius End Stage Renal Disease (ESRD) Treatment Introduction
11.1.4 Fresenius Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.1.5 Fresenius Recent Development
11.2 DaVita
11.2.1 DaVita Company Detail
11.2.2 DaVita Business Overview
11.2.3 DaVita End Stage Renal Disease (ESRD) Treatment Introduction
11.2.4 DaVita Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.2.5 DaVita Recent Development
11.3 Baxter
11.3.1 Baxter Company Detail
11.3.2 Baxter Business Overview
11.3.3 Baxter End Stage Renal Disease (ESRD) Treatment Introduction
11.3.4 Baxter Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.3.5 Baxter Recent Development
11.4 Nipro
11.4.1 Nipro Company Detail
11.4.2 Nipro Business Overview
11.4.3 Nipro End Stage Renal Disease (ESRD) Treatment Introduction
11.4.4 Nipro Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.4.5 Nipro Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Detail
11.5.2 B. Braun Business Overview
11.5.3 B. Braun End Stage Renal Disease (ESRD) Treatment Introduction
11.5.4 B. Braun Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.5.5 B. Braun Recent Development
11.6 Asahi Kasei
11.6.1 Asahi Kasei Company Detail
11.6.2 Asahi Kasei Business Overview
11.6.3 Asahi Kasei End Stage Renal Disease (ESRD) Treatment Introduction
11.6.4 Asahi Kasei Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.6.5 Asahi Kasei Recent Development
11.7 Nikkiso
11.7.1 Nikkiso Company Detail
11.7.2 Nikkiso Business Overview
11.7.3 Nikkiso End Stage Renal Disease (ESRD) Treatment Introduction
11.7.4 Nikkiso Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.7.5 Nikkiso Recent Development
11.8 WEGO
11.8.1 WEGO Company Detail
11.8.2 WEGO Business Overview
11.8.3 WEGO End Stage Renal Disease (ESRD) Treatment Introduction
11.8.4 WEGO Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.8.5 WEGO Recent Development
11.9 Newsol
11.9.1 Newsol Company Detail
11.9.2 Newsol Business Overview
11.9.3 Newsol End Stage Renal Disease (ESRD) Treatment Introduction
11.9.4 Newsol Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.9.5 Newsol Recent Development
11.10 Mayo Clinic
11.10.1 Mayo Clinic Company Detail
11.10.2 Mayo Clinic Business Overview
11.10.3 Mayo Clinic End Stage Renal Disease (ESRD) Treatment Introduction
11.10.4 Mayo Clinic Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.10.5 Mayo Clinic Recent Development
11.11 Guangdong Biolight
11.11.1 Guangdong Biolight Company Detail
11.11.2 Guangdong Biolight Business Overview
11.11.3 Guangdong Biolight End Stage Renal Disease (ESRD) Treatment Introduction
11.11.4 Guangdong Biolight Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.11.5 Guangdong Biolight Recent Development
11.12 Medtronic
11.12.1 Medtronic Company Detail
11.12.2 Medtronic Business Overview
11.12.3 Medtronic End Stage Renal Disease (ESRD) Treatment Introduction
11.12.4 Medtronic Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.12.5 Medtronic Recent Development
11.13 Sanxin Medtec
11.13.1 Sanxin Medtec Company Detail
11.13.2 Sanxin Medtec Business Overview
11.13.3 Sanxin Medtec End Stage Renal Disease (ESRD) Treatment Introduction
11.13.4 Sanxin Medtec Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.13.5 Sanxin Medtec Recent Development
11.14 Jafron Biomedical
11.14.1 Jafron Biomedical Company Detail
11.14.2 Jafron Biomedical Business Overview
11.14.3 Jafron Biomedical End Stage Renal Disease (ESRD) Treatment Introduction
11.14.4 Jafron Biomedical Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.14.5 Jafron Biomedical Recent Development
11.15 SWS Hemodialysis Care
11.15.1 SWS Hemodialysis Care Company Detail
11.15.2 SWS Hemodialysis Care Business Overview
11.15.3 SWS Hemodialysis Care End Stage Renal Disease (ESRD) Treatment Introduction
11.15.4 SWS Hemodialysis Care Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.15.5 SWS Hemodialysis Care Recent Development
11.16 Tianyi Medical
11.16.1 Tianyi Medical Company Detail
11.16.2 Tianyi Medical Business Overview
11.16.3 Tianyi Medical End Stage Renal Disease (ESRD) Treatment Introduction
11.16.4 Tianyi Medical Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
11.16.5 Tianyi Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global End Stage Renal Disease (ESRD) Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Hemodialysis
Table 3. Key Players of Peritoneal Dialysis
Table 4. Key Players of Kidney Transplantation
Table 5. Global End Stage Renal Disease (ESRD) Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global End Stage Renal Disease (ESRD) Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global End Stage Renal Disease (ESRD) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global End Stage Renal Disease (ESRD) Treatment Market Share by Region (2019-2024)
Table 9. Global End Stage Renal Disease (ESRD) Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global End Stage Renal Disease (ESRD) Treatment Market Share by Region (2025-2030)
Table 11. End Stage Renal Disease (ESRD) Treatment Market Trends
Table 12. End Stage Renal Disease (ESRD) Treatment Market Drivers
Table 13. End Stage Renal Disease (ESRD) Treatment Market Challenges
Table 14. End Stage Renal Disease (ESRD) Treatment Market Restraints
Table 15. Global End Stage Renal Disease (ESRD) Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global End Stage Renal Disease (ESRD) Treatment Market Share by Players (2019-2024)
Table 17. Global Top End Stage Renal Disease (ESRD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease (ESRD) Treatment as of 2023)
Table 18. Ranking of Global Top End Stage Renal Disease (ESRD) Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by End Stage Renal Disease (ESRD) Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players End Stage Renal Disease (ESRD) Treatment Product Solution and Service
Table 22. Date of Enter into End Stage Renal Disease (ESRD) Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global End Stage Renal Disease (ESRD) Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global End Stage Renal Disease (ESRD) Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global End Stage Renal Disease (ESRD) Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global End Stage Renal Disease (ESRD) Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global End Stage Renal Disease (ESRD) Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global End Stage Renal Disease (ESRD) Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global End Stage Renal Disease (ESRD) Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global End Stage Renal Disease (ESRD) Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America End Stage Renal Disease (ESRD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America End Stage Renal Disease (ESRD) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America End Stage Renal Disease (ESRD) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe End Stage Renal Disease (ESRD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe End Stage Renal Disease (ESRD) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe End Stage Renal Disease (ESRD) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America End Stage Renal Disease (ESRD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America End Stage Renal Disease (ESRD) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America End Stage Renal Disease (ESRD) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Fresenius Company Detail
Table 48. Fresenius Business Overview
Table 49. Fresenius End Stage Renal Disease (ESRD) Treatment Product
Table 50. Fresenius Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 51. Fresenius Recent Development
Table 52. DaVita Company Detail
Table 53. DaVita Business Overview
Table 54. DaVita End Stage Renal Disease (ESRD) Treatment Product
Table 55. DaVita Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 56. DaVita Recent Development
Table 57. Baxter Company Detail
Table 58. Baxter Business Overview
Table 59. Baxter End Stage Renal Disease (ESRD) Treatment Product
Table 60. Baxter Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 61. Baxter Recent Development
Table 62. Nipro Company Detail
Table 63. Nipro Business Overview
Table 64. Nipro End Stage Renal Disease (ESRD) Treatment Product
Table 65. Nipro Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 66. Nipro Recent Development
Table 67. B. Braun Company Detail
Table 68. B. Braun Business Overview
Table 69. B. Braun End Stage Renal Disease (ESRD) Treatment Product
Table 70. B. Braun Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 71. B. Braun Recent Development
Table 72. Asahi Kasei Company Detail
Table 73. Asahi Kasei Business Overview
Table 74. Asahi Kasei End Stage Renal Disease (ESRD) Treatment Product
Table 75. Asahi Kasei Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 76. Asahi Kasei Recent Development
Table 77. Nikkiso Company Detail
Table 78. Nikkiso Business Overview
Table 79. Nikkiso End Stage Renal Disease (ESRD) Treatment Product
Table 80. Nikkiso Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 81. Nikkiso Recent Development
Table 82. WEGO Company Detail
Table 83. WEGO Business Overview
Table 84. WEGO End Stage Renal Disease (ESRD) Treatment Product
Table 85. WEGO Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 86. WEGO Recent Development
Table 87. Newsol Company Detail
Table 88. Newsol Business Overview
Table 89. Newsol End Stage Renal Disease (ESRD) Treatment Product
Table 90. Newsol Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 91. Newsol Recent Development
Table 92. Mayo Clinic Company Detail
Table 93. Mayo Clinic Business Overview
Table 94. Mayo Clinic End Stage Renal Disease (ESRD) Treatment Product
Table 95. Mayo Clinic Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 96. Mayo Clinic Recent Development
Table 97. Guangdong Biolight Company Detail
Table 98. Guangdong Biolight Business Overview
Table 99. Guangdong Biolight End Stage Renal Disease (ESRD) Treatment Product
Table 100. Guangdong Biolight Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 101. Guangdong Biolight Recent Development
Table 102. Medtronic Company Detail
Table 103. Medtronic Business Overview
Table 104. Medtronic End Stage Renal Disease (ESRD) Treatment Product
Table 105. Medtronic Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 106. Medtronic Recent Development
Table 107. Sanxin Medtec Company Detail
Table 108. Sanxin Medtec Business Overview
Table 109. Sanxin Medtec End Stage Renal Disease (ESRD) Treatment Product
Table 110. Sanxin Medtec Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 111. Sanxin Medtec Recent Development
Table 112. Jafron Biomedical Company Detail
Table 113. Jafron Biomedical Business Overview
Table 114. Jafron Biomedical End Stage Renal Disease (ESRD) Treatment Product
Table 115. Jafron Biomedical Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 116. Jafron Biomedical Recent Development
Table 117. SWS Hemodialysis Care Company Detail
Table 118. SWS Hemodialysis Care Business Overview
Table 119. SWS Hemodialysis Care End Stage Renal Disease (ESRD) Treatment Product
Table 120. SWS Hemodialysis Care Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 121. SWS Hemodialysis Care Recent Development
Table 122. Tianyi Medical Company Detail
Table 123. Tianyi Medical Business Overview
Table 124. Tianyi Medical End Stage Renal Disease (ESRD) Treatment Product
Table 125. Tianyi Medical Revenue in End Stage Renal Disease (ESRD) Treatment Business (2019-2024) & (US$ Million)
Table 126. Tianyi Medical Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global End Stage Renal Disease (ESRD) Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global End Stage Renal Disease (ESRD) Treatment Market Share by Type: 2023 VS 2030
Figure 3. Hemodialysis Features
Figure 4. Peritoneal Dialysis Features
Figure 5. Kidney Transplantation Features
Figure 6. Global End Stage Renal Disease (ESRD) Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global End Stage Renal Disease (ESRD) Treatment Market Share by Application: 2023 VS 2030
Figure 8. Hospitals Case Studies
Figure 9. Kidney Dialysis Centers Case Studies
Figure 10. At Homes Case Studies
Figure 11. Others Case Studies
Figure 12. End Stage Renal Disease (ESRD) Treatment Report Years Considered
Figure 13. Global End Stage Renal Disease (ESRD) Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 14. Global End Stage Renal Disease (ESRD) Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global End Stage Renal Disease (ESRD) Treatment Market Share by Region: 2023 VS 2030
Figure 16. Global End Stage Renal Disease (ESRD) Treatment Market Share by Players in 2023
Figure 17. Global Top End Stage Renal Disease (ESRD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease (ESRD) Treatment as of 2023)
Figure 18. The Top 10 and 5 Players Market Share by End Stage Renal Disease (ESRD) Treatment Revenue in 2023
Figure 19. North America End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. North America End Stage Renal Disease (ESRD) Treatment Market Share by Country (2019-2030)
Figure 21. United States End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Canada End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe End Stage Renal Disease (ESRD) Treatment Market Share by Country (2019-2030)
Figure 25. Germany End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. France End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. U.K. End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Italy End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Russia End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Nordic Countries End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific End Stage Renal Disease (ESRD) Treatment Market Share by Region (2019-2030)
Figure 33. China End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Japan End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. South Korea End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Southeast Asia End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. India End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Australia End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America End Stage Renal Disease (ESRD) Treatment Market Share by Country (2019-2030)
Figure 41. Mexico End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Brazil End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa End Stage Renal Disease (ESRD) Treatment Market Share by Country (2019-2030)
Figure 45. Turkey End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Saudi Arabia End Stage Renal Disease (ESRD) Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Fresenius Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 48. DaVita Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 49. Baxter Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 50. Nipro Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 51. B. Braun Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 52. Asahi Kasei Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 53. Nikkiso Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 54. WEGO Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 55. Newsol Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 56. Mayo Clinic Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 57. Guangdong Biolight Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 58. Medtronic Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 59. Sanxin Medtec Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 60. Jafron Biomedical Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 61. SWS Hemodialysis Care Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 62. Tianyi Medical Revenue Growth Rate in End Stage Renal Disease (ESRD) Treatment Business (2019-2024)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock